Skip to content

Clinical application of neuromuscular electrical stimulation in the prevention of venous thromboembolism in patients after orthopedic surgery

Clinical application of neuromuscular electrical stimulation in the prevention of venous thromboembolism in patients after orthopedic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068832
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with knee osteoarthritis

Interventions

Experimental group:Postoperative conventional treatment is combined with neuromuscular electrical stimulation
Control group:Conventional postoperative treatment

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age greater than or equal to 18 years and less than 75 years old; 2.post-orthopedic surgery (after surgery for fractures of the spine, pelvis, lower extremities, after hip and knee replacement); 3. No clear thromboembolism; 4. Generally good, no serious life-threatening primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system; 5. Have not participated in any clinical trials in the past 3 months; 6. Voluntarily participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with serious life-threatening primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system and psychosis; 2. It is clear that there is deep vein thromboembolism; 3. There is local skin damage at the application site of the equipment; 4. Those with unstable vital signs; 5. Patients with electrode allergy; 6. Those with severe coagulation dysfunction; 7. Pregnancy; 8. Pacemakers or implantable defibrillators; 9. Those who are unwilling or unable to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Incidence of venous thrombosis;

Secondary

MeasureTime frame
Hemodynamic parameters;D-dimer, fibrinogen, thromboelastogram values;Leg circumference measurement;Lower extremity muscle modulus of elasticity;Lower extremity surface EMG values;

Countries

China

Contacts

Public ContactJianxiong Wang

Affiliated Hospital of Southwest Medical University

380030472@qq.com+86 18283012266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026